Falorni Tech Glass Melting Technology

Bormioli Pharma: 47% increase in North American sales for 2023

Bormioli Pharma has announced a significant increase of 47 percent in its North American sales for 2023. This notable growth is a direct result of the company’s rapidly evolving infrastructure and expanded capacity, tailored to meet the unique demands of the North American pharmaceutical market, including an increased need for pharmaceutical glass vials.

Bormioli Pharma strengthened its strategic focus on the US market four years ago by establishing a new legal entity and a commercial branch in the US. From then on, the company’s on-site commercial team has been expanded, an FDA-approved warehouse established, and dedicated product offerings compatible with regional standards have been designed. For North American customers, this translates into the availability of a reliable and flexible packaging partner that can streamline their purchasing processes while reducing supply chain complexity, shortening their time-to-market and supporting them in the development of high-value projects with local, qualified support.

“As we grow our presence in North America and expand our capabilities to meet regional standards, we are committed to the partnerships that enable us to broaden our reach,” said Johann Depperschmidt, Bormioli Pharma’s Head of Sales, Americas. “To best serve our North American customers, we’ve adapted our manufacturing processes to produce Type I Glass expansion 33 vials in our European facilities, ensuring robust production and backup. We have an on-site, dedicated US sales team and a local warehouse, and we look forward to expanding these resources further in 2024. Additionally, we are collaborating with a US-based sterilization company to prepare ready-to-use packaging kits.”

Bormioli Pharma’s CEO, Andrea Lodetti, noted, “Our momentous growth in the North American market embodies our dedication to meeting and exceeding the evolving needs of this dynamic market. We are not just expanding our footprint but also enhancing our efficiency and adaptability. This growth aligns perfectly with our mission to provide innovative and sustainable pharmaceutical packaging solutions, and we are proud to say that our growth is not only robust but also responsible.”

Sign up for free to the daily newsletter

Subscribe now to our daily newsletter for full coverage of everything you need to know about the world glass industry!

We don't send spam! Read our Privacy Policy for more information.

Share this article
Related news